As Kebotix’s second largest backer, Toronto-based ArcTern Ventures is instrumental as the startup scales operations and boosts R&D efforts to generate discoveries of urgent global importance – a key theme within ArcTern’s portfolio of cleantech companies.
FREMONT, CA: Kebotix, a Cambridge-based technology platform company for new chemicals and materials, declared ArcTern Ventures as a major investor in its Series A funding that raised $11.4 million. The funding was led by Denmark-based Novo Holdings, a leading international life science investor.
As Kebotix’s second-largest backer, Toronto-based ArcTern Ventures is instrumental as the startup scales operations and boosts R&D efforts to generate discoveries of urgent global importance – a key theme within ArcTern’s portfolio of cleantech companies.
“We’re looking for companies that solve big problems related to climate change and sustainability,” stated Murray McCaig, ArcTern co-founder and managing partner. “Kebotix brings to our portfolio a unique platform technology that can significantly mitigate environmental impacts of chemicals in the market today, enable rapid acceleration in the adoption of new planet-positive technologies across a range of industries and use cases, and shave years and millions of dollars off this timeline by bringing the chemical discovery process into the 21st century.”
ArcTern joins a list of investors that includes Baidu Ventures, One Way Ventures, Embark Ventures, Flybridge Ventures, and Propagator Ventures, in addition to Novo.
“Proud as we are to be part of one of North America’s leading cleantech venture funds, Kebotix considers ArcTern Ventures as more than an investor,” stated Dr. Jill S. Becker, Kebotix CEO and founder. “We see ArcTern as a Canadian ambassador with close connections to our expanding ecosystem. Their offices are literally across the street from The Matter Lab, where AlánAspuru-Guzik, Kebotix’s chief visionary officer and founder, is leading breakthrough research as professor of chemistry and computer science at the University of Toronto.”
Kebotix, launched in late 2018, engages with major players in public and private sectors, demanding breakthroughs in faster, cost-effective discovery of materials and chemicals. Among other macro efforts, Kebotix is committed to improving public health, championing sustainability, and eliminating the production of hazardous substances through Green Chemistry solutions.